title: Phenotypic differences in virulence and immune response in closely related clinical isolates of influenza A 2009 H1N1 pandemic viruses in mice.
abstract: To capture the possible genotypic and phenotypic differences of the 2009 influenza A virus H1N1 pandemic (H1N1pdm) strains circulating in adult hospitalized patients, we isolated and sequenced nine H1N1pdm viruses from patients hospitalized during 2009-2010 with severe influenza pneumonia in Kentucky. Each viral isolate was characterized in mice along with two additional H1N1 pandemic strains and one seasonal strain to assess replication and virulence. All isolates showed similar levels of replication in nasal turbinates and lung, but varied in their ability to cause morbidity. Further differences were identified in cytokine and chemokine responses. IL-6 and KC were expressed early in mice infected with strains associated with higher virulence. Strains that showed lower pathogenicity in mice had greater IFNγ, MIG, and IL-10 responses. A principal component analysis (PCA) of the cytokine and chemokine profiles revealed 4 immune response phenotypes that correlated with the severity of disease. A/KY/180/10, which showed the greatest virulence with a rapid onset of disease progression, was compared in additional studies with A/KY/136/09, which showed low virulence in mice. Analyses comparing a low (KY/136) versus a high (KY/180) virulent isolate showed a significant difference in the kinetics of infection within the lower respiratory tract and immune responses. Notably by 4 DPI, virus titers within the lung, bronchoalveolar lavage fluid (BALf), and cells within the BAL (BALc) revealed that the KY/136 replicated in BALc, while KY/180 replication persisted in lungs and BALc. In summary, our studies suggest four phenotypic groups based on immune responses that result in different virulence outcomes in H1N1pdm isolates with a high degree of genetic similarity. In vitro studies with two of these isolates suggested that the more virulent isolate, KY/180, replicates productively in macrophages and this may be a key determinant in tipping the response toward a more severe disease progression.
authors: Department of Microbiology and Immunology, University of Louisville, Kentucky, United States of America.
authors: Jeremy V
authors: JV
authors: Camp
authors: Yong-Kyu
authors: YK
authors: Chu
authors: Dong-Hoon
authors: DH
authors: Chung
authors: Ryan C
authors: RC
authors: McAllister
authors: Robert S
authors: RS
authors: Adcock
authors: Rachael L
authors: RL
authors: Gerlach
authors: Timothy L
authors: TL
authors: Wiemken
authors: Paula
authors: P
authors: Peyrani
authors: Julio A
authors: JA
authors: Ramirez
authors: James T
authors: JT
authors: Summersgill
authors: Colleen B
authors: CB
authors: Jonsson
mesh_terms: D000328:Adult; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood / Q000276:immunology; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology / Q000276:immunology; D002460:Cell Line; D016207:Cytokines / Q000378:metabolism; D005260:Female; D005814:Genes, Viral; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood / Q000276:immunology; D053118:Influenza A Virus, H1N1 Subtype / Q000302:isolation & purification / Q000502:physiology*; D007251:Influenza, Human / Q000276:immunology / Q000821:virology; D008168:Lung / Q000276:immunology / Q000378:metabolism / Q000821:virology; D008264:Macrophages / Q000276:immunology / Q000821:virology; D008297:Male; D051379:Mice; D008875:Middle Aged; D009976:Orthomyxoviridae Infections / Q000276:immunology* / Q000401:mortality / Q000821:virology*; D010641:Phenotype; D025341:Principal Component Analysis; D014774:Virulence; D014779:Virus Replication; D015431:Weight Loss
chemical_list: D000914:Antibodies, Viral; D016207:Cytokines; D007074:Immunoglobulin G